{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T15:40:08Z","timestamp":1791906008551,"version":"4.3.4"},"reference-count":24,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2012,2,1]],"date-time":"2012-02-01T00:00:00Z","timestamp":1328054400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Thrombosis Research"],"published-print":{"date-parts":[[2012,2]]},"DOI":"10.1016\/j.thromres.2011.07.024","type":"journal-article","created":{"date-parts":[[2011,9,25]],"date-time":"2011-09-25T10:22:11Z","timestamp":1316946131000},"page":"146-151","source":"Crossref","is-referenced-by-count":94,"title":["Thromboembolic safety and efficacy of prothrombin complex concentrates in the emergency reversal of warfarin coagulopathy"],"prefix":"10.1016","volume":"129","author":[{"given":"Ammar","family":"Majeed","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Eelde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"\u00c5gren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sam","family":"Schulman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margareta","family":"Holmstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.thromres.2011.07.024_bb0005","doi-asserted-by":"crossref","first-page":"257S","DOI":"10.1378\/chest.08-0674","article-title":"Hemorrhagic complications of anticoagulant and thrombolytic treatment: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)","volume":"133","author":"Schulman","year":"2008","journal-title":"Chest"},{"key":"10.1016\/j.thromres.2011.07.024_bb0010","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1001\/archneur.57.12.1710","article-title":"Safety of discontinuation of anticoagulation in patients with intracranial hemorrhage at high thromboembolic risk","volume":"57","author":"Phan","year":"2000","journal-title":"Arch Neurol"},{"key":"10.1016\/j.thromres.2011.07.024_bb0015","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1055\/s-0037-1613443","article-title":"Predisposing factors for enlargement of intracerebral hemorrhage in patients treated with warfarin","volume":"89","author":"Yasaka","year":"2003","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.thromres.2011.07.024_bb0020","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1161\/01.STR.0000221786.81354.d6","article-title":"Hematoma growth and outcome in treated neurocritical care patients with intracerebral hemorrhage related to oral anticoagulant therapy: comparison of acute treatment strategies using vitamin K, fresh frozen plasma, and prothrombin complex concentrates","volume":"37","author":"Huttner","year":"2006","journal-title":"Stroke"},{"key":"10.1016\/j.thromres.2011.07.024_bb0025","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1212\/01.WNL.0000138428.40673.83","article-title":"Warfarin, hematoma expansion, and outcome of intracerebral hemorrhage","volume":"63","author":"Flibotte","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.thromres.2011.07.024_bb0030","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1055\/s-0038-1655992","article-title":"Emergency oral anticoagulant reversal: the relative efficacy of infusions of fresh frozen plasma and clotting factor concentrate on correction of the coagulopathy","volume":"77","author":"Makris","year":"1997","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.thromres.2011.07.024_bb0035","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1212\/01.wnl.0000238104.75563.2f","article-title":"Progression of warfarin-associated intracerebral hemorrhage after INR normalization with FFP","volume":"67","author":"Lee","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.thromres.2011.07.024_bb0040","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1423-0410.2005.00648.x","article-title":"Transfusion-related acute lung injury (TRALI): a serious adverse event of blood transfusion","volume":"89","author":"Bux","year":"2005","journal-title":"Vox Sang"},{"key":"10.1016\/j.thromres.2011.07.024_bb0045","first-page":"3","article-title":"Thrombogenicity associated with factor IX complex concentrates","volume":"28","author":"Lusher","year":"1991","journal-title":"Semin Hematol"},{"key":"10.1016\/j.thromres.2011.07.024_bb0050","doi-asserted-by":"crossref","unstructured":"Rosovsky RP, Crowther MA. What is the evidence for the off-label use of recombinant factor VIIa (rFVIIa) in the acute reversal of warfarin? ASH evidence-based review 2008. Hematology \/ the Education Program of the American Society of Hematology. American Society of Hematology. Education Program. 2008:36\u20138.","DOI":"10.1182\/asheducation-2008.1.36"},{"key":"10.1016\/j.thromres.2011.07.024_bb0055","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1056\/NEJMoa1006221","article-title":"Safety of recombinant activated factor VII in randomized clinical trials","volume":"363","author":"Levi","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.thromres.2011.07.024_bb0060","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1056\/NEJMcp025373","article-title":"Clinical practice. Care of patients receiving long-term anticoagulant therapy","volume":"349","author":"Schulman","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.thromres.2011.07.024_bb0065","doi-asserted-by":"crossref","first-page":"2860","DOI":"10.1161\/STROKEAHA.110.593087","article-title":"Optimal timing of resumption of warfarin after intracranial hemorrhage","volume":"41","author":"Majeed","year":"2010","journal-title":"Stroke"},{"key":"10.1016\/j.thromres.2011.07.024_bb0070","doi-asserted-by":"crossref","first-page":"365","DOI":"10.5694\/j.1326-5377.2006.tb00277.x","article-title":"Prothrombinex use for the reversal of warfarin: is fresh frozen plasma needed?","volume":"184","author":"Crawford","year":"2006","journal-title":"Med J Aust"},{"issue":"suppl. S1","key":"10.1016\/j.thromres.2011.07.024_bb0075","first-page":"1","article-title":"Use and efficacy of prothrombin complex concentrate in the west of Scotland 2007\u20132008","volume":"145","author":"DA","year":"2009","journal-title":"bjh"},{"key":"10.1016\/j.thromres.2011.07.024_bb0080","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1186\/cc5536","article-title":"Octaplex in routine clinical use for prophylaxis and therapy of bleeding in patients with prothrombin complex factor deficiency","volume":"11","author":"Franken","year":"2007","journal-title":"Crit Care"},{"key":"10.1016\/j.thromres.2011.07.024_bb0085","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1007\/s00134-007-0528-z","article-title":"Ultra-rapid management of oral anticoagulant therapy-related surgical intracranial hemorrhage","volume":"33","author":"Vigue","year":"2007","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.thromres.2011.07.024_bb0090","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.thromres.2005.08.005","article-title":"Individualized dosing regimen for prothrombin complex concentrate more effective than standard treatment in the reversal of oral anticoagulant therapy: an open, prospective randomized controlled trial","volume":"118","author":"van Aart","year":"2006","journal-title":"Thromb Res"},{"key":"10.1016\/j.thromres.2011.07.024_bb0095","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1001\/archinte.163.8.901","article-title":"Perioperative management of patients receiving oral anticoagulants: a systematic review","volume":"163","author":"Dunn","year":"2003","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.thromres.2011.07.024_bb0100","first-page":"373","article-title":"Perioperative bridging interruption with heparin for the patient receiving long-term anticoagulation","volume":"11","author":"Spyropoulos","year":"2005","journal-title":"Curr Opin Pulm Med"},{"key":"10.1016\/j.thromres.2011.07.024_bb0105","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1111\/j.1538-7836.2008.02904.x","article-title":"Prothrombin complex concentrate (Beriplex P\/N) for emergency anticoagulation reversal: a prospective multinational clinical trial","volume":"6","author":"Pabinger","year":"2008","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.thromres.2011.07.024_bb0110","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1111\/j.1538-7836.2006.01815.x","article-title":"Urgent reversal of warfarin with prothrombin complex concentrate","volume":"4","author":"Lankiewicz","year":"2006","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.thromres.2011.07.024_bb0115","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1136\/hrt.2010.198275","article-title":"Reducing the risk of venous thromboembolism (deep vein thrombosis and pulmonary embolism) in patients admitted to hospital: summary of the NICE guideline","volume":"96","author":"Hill","year":"2010","journal-title":"Heart"},{"key":"10.1016\/j.thromres.2011.07.024_bb0120","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1016\/S0140-6736(08)60601-7","article-title":"Effects of extended-release metoprolol succinate in patients undergoing non-cardiac surgery (POISE trial): a randomised controlled trial","volume":"371","author":"Devereaux","year":"2008","journal-title":"Lancet"}],"container-title":["Thrombosis Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384811003707?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384811003707?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,6,24]],"date-time":"2020-06-24T23:40:13Z","timestamp":1593042013000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049384811003707"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,2]]},"references-count":24,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,2]]}},"alternative-id":["S0049384811003707"],"URL":"https:\/\/doi.org\/10.1016\/j.thromres.2011.07.024","relation":{},"ISSN":["0049-3848"],"issn-type":[{"value":"0049-3848","type":"print"}],"subject":[],"published":{"date-parts":[[2012,2]]}}}